United States · Platforms & data · MarketBeat

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

Published by MarketBeat · United States 2 h ago

Cybin (NASDAQ:HELP) outlined plans for two late-stage mental health programs, with top-line data from its Phase III APPROACH study of HLP003 in major depressive disorder expected…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

MarketWatch

We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?

The Motley Fool

General Motors' Q3 Sales Slipped. Its Profits Soared. Here Are 3 Takeaways Investors Must Note.

Investing.com

Lam Research earnings beat by $0.02, revenue topped estimates

CNBC

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Yahoo Finance